Sign in
4

Changes in Ownership

ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-26-045108

General Counsel sold 677 shares at $2.18 ($1,475)

From the SEC's structured data for this filing

Trades in this filing

Wilson Martin · General Counsel

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-11-18 Sale : show line 1 in the form −677 $2.18 $1,475 540,336 D
Open-market sales · 677 sh · avg $2.18 · $1,475
Loading xslF345X06/form4.xml…